| __timestamp | Takeda Pharmaceutical Company Limited | Taro Pharmaceutical Industries Ltd. |
|---|---|---|
| Wednesday, January 1, 2014 | 382096000000 | 55430000 |
| Thursday, January 1, 2015 | 345927000000 | 65510000 |
| Friday, January 1, 2016 | 312303000000 | 71160000 |
| Sunday, January 1, 2017 | 325441000000 | 70644000 |
| Monday, January 1, 2018 | 368298000000 | 70418000 |
| Tuesday, January 1, 2019 | 492381000000 | 63238000 |
| Wednesday, January 1, 2020 | 455833000000 | 59777000 |
| Friday, January 1, 2021 | 526087000000 | 60152000 |
| Saturday, January 1, 2022 | 633325000000 | 54540000 |
| Sunday, January 1, 2023 | 729924000000 | 52243000 |
| Monday, January 1, 2024 | 729924000000 | 64536000 |
Unleashing insights
In the competitive world of pharmaceuticals, innovation is key. Over the past decade, Takeda Pharmaceutical Company Limited has consistently outpaced Taro Pharmaceutical Industries Ltd. in research and development (R&D) spending. From 2014 to 2023, Takeda's R&D expenses surged by approximately 91%, peaking in 2023. In contrast, Taro's investment remained relatively stable, with a modest increase of around 16% over the same period.
Takeda's commitment to innovation is evident, with its R&D spending in 2023 being nearly 100 times that of Taro. This significant investment underscores Takeda's strategy to lead in pharmaceutical advancements. Meanwhile, Taro's steady approach suggests a focus on optimizing existing resources.
As we look to the future, Takeda's aggressive R&D strategy may position it as a leader in new drug development, while Taro's consistent investment could ensure steady growth in its niche markets.
Who Prioritizes Innovation? R&D Spending Compared for Takeda Pharmaceutical Company Limited and CymaBay Therapeutics, Inc.
Analyzing R&D Budgets: Takeda Pharmaceutical Company Limited vs Amicus Therapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Takeda Pharmaceutical Company Limited and Soleno Therapeutics, Inc.
Comparing Innovation Spending: Takeda Pharmaceutical Company Limited and MannKind Corporation
Who Prioritizes Innovation? R&D Spending Compared for Takeda Pharmaceutical Company Limited and Travere Therapeutics, Inc.
Takeda Pharmaceutical Company Limited or Viridian Therapeutics, Inc.: Who Invests More in Innovation?
Who Prioritizes Innovation? R&D Spending Compared for BioMarin Pharmaceutical Inc. and Taro Pharmaceutical Industries Ltd.
R&D Spending Showdown: Opthea Limited vs Taro Pharmaceutical Industries Ltd.
Comparing Innovation Spending: MorphoSys AG and Taro Pharmaceutical Industries Ltd.
R&D Insights: How Bausch Health Companies Inc. and Taro Pharmaceutical Industries Ltd. Allocate Funds
Geron Corporation or Taro Pharmaceutical Industries Ltd.: Who Invests More in Innovation?
Taro Pharmaceutical Industries Ltd. vs Evotec SE: Strategic Focus on R&D Spending